Menstrual Suppression with the Levonorgestrel Intrauterine System in Girls with Developmental Delay

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 5, 2012, Pages 308-313

  Adams Hillard, Paula J ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Adolescent; Developmental delay; Levonorgestrel intrauterine system; Menstrual suppression; Therapeutic amenorrhea

Indexed keywords

LEVONORGESTREL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMORBIDITY; DEVELOPMENTAL DISORDER; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HORMONAL THERAPY; HUMAN; MEDICAL RECORD REVIEW; MENSTRUAL SUPPRESSION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; COMORBIDITY; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENSTRUATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84866278460     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.05.005     Document Type: Article

References (34)

1. Quint E.H. The conservative management of abnormal bleeding in teenagers with developmental disabilities. J Pediatr Adolesc Gynecol 2003, 16:54.
2. Dizon C.D., Allen L.M., Ornstein M.P. Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto. J Pediatr Adolesc Gynecol 2005, 18:157.
3. Backeljauw P., Rose, Lawson M. Clinical management of menstruation in adolescent females with developmental delay. Endocrinologist 2004, 14:87.
4. Grover S.R. Menstrual and contraceptive management in women with an intellectual disability. Med J Aust 2002, 176:108.
5. ACOG Committee Opinion no. 448: Menstrual manipulation for adolescents with disabilities. Obstet Gynecol 2009, 114:1428. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care.
6. Atkinson E., Bennett M.J., Dudley J., et al. Consensus statement: Menstrual and contraceptive management in women with an intellectual disability. Aust N Z J Obstet Gynaecol 2003, 43:109. Australian Society of Paediatric and Adolescent Gynaecology Working Party.
7. Carr E.G., Smith C.E., Giacin T.A., et al. Menstrual discomfort as a biological setting event for severe problem behavior: assessment and intervention. Am J Ment Retard 2003, 108:117.
8. Tharinger D., Horton C.B., Millea S. Sexual abuse and exploitation of children and adults with mental retardation and other handicaps. Child Abuse Negl 1990, 14:301.
9. Shropshire L., Morris W.M., Foote E.L. Suppression of menstruation. A hygienic measure in the care of mentally retarded patients. JAMA 1967, 200:414.
10. Dapunt O. [Experiences with therapeutic amenorrhea]. Zentralblr Gynakol 1965, 87:896.
11. Laros R.K. Therapeutic amenorrhea in hematologic disorders. Obstet Gynecol 1971, 38:589.
12. Lydecken K. Therapeutic amenorrhea induced with lynestrenol in mentally retarded. Acta Psychiatr Scand Suppl 1972, 229:7.
13. Mölsä P.K. Inducement of therapeutic amenorrhea in mentally retarded women: two-year follow-up study. Am J Ment Deficiency 1986, 90:591.
14. Huovinen K.J., Lahteenmaki P., Karkkainen J., et al. Lynestrenol induced therapeutic amenorrhea: effects of dose reduction on serum sex-hormones and lipids. Acta Obstet Gynecol Scand 1992, 71:175.
15. Hillard P.J. Therapeutic amenorrhea. J Pediatr Hematol Oncol 1999, 21:350.
16. Isley M.M., Kaunitz A.M. Update on hormonal contraception and bone density. Rev Endocr Metab Disord 2011, 12:93.
17. Harel Z., Johnson C.C., Gold M.A., et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010, 81:281.
18. ACOG Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives. Obstet Gynecol 2010, 115:206.
19. Hidalgo M., Bahamondes L., Perrotti M., et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002, 65:129.
20. Schwallie P.C., Assenzo J.R. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973, 24:331.
21. Bahamondes M.V., Monteiro I., Castro S., et al. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Hum Reprod 2010, 25:1158.
22. Albanese A., Hopper N.W. Suppression of menstruation in adolescents with severe learning disabilities. Arch Dis Child 2007, 92:629.
23. Pillai M., O'Brien K., Hill E. The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities. BJOG 2010, 117:216.
24. Jayasinghe K, Moore P, Jayasinghe Y, et al: The use of levonorgestrel intrauterine system in adolescents. Abstract presented at the North American Society for Pediatric and Adolescent Gynecology. Orlando, FL: May 18, 2006.
25. Paterson H., Ashton J., Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 2009, 79:433.
26. Zurawin R.K., Paransky O.I. The role of surgical techniques in the treatment of menstrual problems and as contraception in adolescents with disabilities. J Pediatr Adolesc Gynecol 2003, 16:51.
27. Yen S., Saah T., Hillard P.J. IUDs and adolescents-an under-utilized opportunity for pregnancy prevention. J Pediatr Adolesc Gynecol 2010, 23:123.
28. Deans E.I., Grimes D.A. Intrauterine devices for adolescents: a systematic review. Contraception 2009, 79:418.
29. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol 2007, 110:1493.
30. Hidalgo M.M., Hidalgo-Regina C., Bahamondes M.V., et al. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system. Contraception 2009, 80:84.
31. Ronnerdag M., Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999, 78:716.
32. Quint E.H., Elkins T.E., Sorg C.A., et al. The treatment of cyclical behavioral changes in women with mental disabilities. J Pediatr Adolesc Gynecol 1999, 12:139.
33. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics. Pediatrics 1995, 95:314.
34. Diekema D.S. Involuntary sterilization of persons with mental retardation: an ethical analysis. Ment Retard Dev Disabil Res Rev 2003, 9:21.